Institutional investors purchased a net $854.6 thousand shares of THRX during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 86.13% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
IRIDIAN ASSET MANAGEMENT LLC Bought 1.4 Million shares of Theravance Inc
BANK OF AMERICA, NA (PRIVATE BAN... Bought 543.7 Thousand shares of Theravance Inc
PARK WEST ASSET MANAGEMENT LLC Bought 409.8 Thousand shares of Theravance Inc